Retrospective study of Initial Acute Decline in eGFR by SGLT2-inhibitor
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000039903
- Lead Sponsor
- Jinnouchi Hospital
- Brief Summary
The mean minimum eGFR early after SGLT2i administration was 34.9 mL/min/1.73 m2, which was significantly lower than before treatment (mean, -7.7%). Seventy patients (80.5%) had IAD-eGFR, and 36 patients (41.4%) had a large IAD-eGFR (more than10%).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 87
Inclusion Criteria
Not provided
Exclusion Criteria
Type 1 DM unstable condition cancer infection
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We retrospectively investigated how much and how frequently IAD-eGFR occurs in T2DM patients with CKD Stage-3b in the real clinical practice.
- Secondary Outcome Measures
Name Time Method